Human herpesvirus 6

Mayo Clinic Proceedings

Volumn 74, Issue 2, 1999, Pages 163-170

  Dockrell, David H ^a   Smith, Thomas F ^a   Paya, Carlos V ^a  

^a MAYO CLINIC ROCHESTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; CYTOMEGALOVIRUS INFECTION; HERPES VIRUS INFECTION; HUMAN; HUMAN HERPESVIRUS 6; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNE DEFICIENCY; MULTIPLE SCLEROSIS; NONHUMAN; PATHOGENESIS; POLYMERASE CHAIN REACTION; SERODIAGNOSIS; VIRUS CULTURE;

EID: 0033043106     PISSN: 00256196     EISSN: None     Source Type: Journal    
DOI: 10.4065/74.2.163     Document Type: Article

References (56)

1. Salahuddin SZ, Ablashi DV, Markham PD, Josephs SF, Sturzenegger S, Kaplan M, et al. Isolation of a new virus, HBLV, in patients with lymphoproliferative disorders. Science 1986:234:596-601
2. Ablashi DV, Salahuddin SZ, Josephs SF, Imam F, Lusso P, Gallo RC, et al. HBLV (or HHV-6) in human cell lines [letter]. Nature 1987:329:207
3. Oren I, Sobel JD. Human herpesvirus type 6: review. Clin Infect Dis 1992;14:741-746
4. Dewhurst S. Newly discovered human herpesviruses (HHV-6 and HHV7). Curr Opin Infect Dis 1994;7:238-245
5. Robinson WS. Human herpesvirus 6. Curr Clin Top Infect Dis 1994:14:159-169
6. Josephs SF, Salahuddin SZ, Ablashi DV, Schachter F, Wong-Staal F, Gallo RC. Genomic analysis of the human B-lymphotropic virus (HBLV). Science 1986;234:601-603
7. Compels UA, Nicholas J, Lawrence G, Jones M, Thomson BJ, Martin MED, et al. The DNA sequence of human herpesvirus-6: structure, coding content, and genome evolution. Virology 1995:209:29-51
8. Efstathiou S, Compels UA, Craxton MA, Honess RW, Ward K. DNA homology between a novel human herpesvirus (HHV-6) and human cytomegalovirus [letter]. Lancet 1988:1:63-64
9. Schirmer EC, Wyatt LS, Yamanishi K, Rodriguez WJ, Frenkel N. Differentiation between two distinct classes of viruses now classified as human herpesvirus 6. Proc A/at/ Acad Sci USA 1991:88:59225926
10. Singh N, Carrigan DR. Human herpesvirus-6 in transplantation: an emerging pathogen. Ann Intern Med 1996;124:1065-1071
11. Ablashi DV, Lusso P, Hung CL, Salahuddin SZ, Josephs SF, Liana T, et al. Utilization of human hematopoietic cell lines for the propagation and characterization of HBLV (human herpesvirus 6). Int J Cancer 1988:42:787-791
12. Lusso P, Gallo RC, DeRocco SE, Markham PD. CD4 is not the membrane receptor for HHV-6 [letter]. Lancet 1989;1:730
13. Pellett PE, Black JB, Yamamoto M. Human herpesvirus 6: the virus and the search for its role as a human pathogen. Adv Virus Res 1992:41:1-52
14. Takasaki T, Ohkawa N, Sano K, Morimatsu S, Nakano T, Nakai M, et al. Electronmicroscopic study of human herpesvirus 6-infected human T cell lines superinfected with human immunodeficiency virus type 1. Acta Virol 1997:41:221-229
15. Tang YW, Espy MJ, Persing DH, Smith TF. Molecular evidence and clinical significance of herpesvirus coinfection in the central nervous system. J Clin Microbiol 1997;35:2869-2872
16. Chou S, Marousek Gl. Homology of the envelope glycoprotein B of human herpesvirus-6 and cytomegalovirus. Virology 1992:191:523528
17. Anderson RA, Liu DX, Compels UA. Definition of a human herpesvirus6 betaherpesvirus-specific domain in glycoprotein gH that governs interaction with glycoprotein gL: substitution of human cytomegalovirus glycoproteins permits group-specific complex formation. Virology 1996:217:517-526
18. Flamand L, Stefanescu I, Ablashi DV, Menezes J. Activation of the Epstein-Barr virus replicative cycle by human herpesvirus 6. J Virol 1993;67:6768-6777
19. Fairfax MR, Schacker T, Cone RW, Collier AC, Corey L. Human herpesvirus 6 DMA in blood cells of human immunodeficiency virusinfected men: correlation of high levels with high CD4 cell counts. J Infect Dis 1994;169:1342-1345
20. Lusso P, Ensoli B, Markham PD, Ablashi DV, Salahuddin SZ, Tschachler E, et al. Productive dual infection of human CD4+ T lymphocytes by HIV-1 and HHV-6. Nature 1989:337:370-373
21. Levy JA, Ferro F, Greenspan D, Lennette ET. Frequent isolation of HHV-6 from saliva and high seroprevalence of the virus in the population. Lancet 1990;335:1047-1050
22. Sieczkowski L, Chandran B, Wood C. The human immunodeficiency virus tat gene enhances replication of human herpesvirus-6. Virology 1995;211:544-553
23. Zhou Y, Chandran B, Wood C. Transcriptional patterns of the pCD41 (U27) locus of human herpesvirus 6. J Virol 1997;71:34203430
24. Levy JA, Landay A, Lennette ET. Human herpesvirus 6 inhibits human immunodeficiency virus type 1 replication in cell culture. J Clin Microbiol 1990:28:2362-2364
25. Lusso P, Malnati MS, Garzino-Demo A, Crowley RW, Long EO, Gallo RC. Infection of natural killer cells by human herpesvirus 6. Nature 1993:362:458-462
26. Lusso P, Garzino-Demo A, Crowley RW, Malnati MS. Infection of y/o T lymphocytes by human herpesvirus 6: transcriptional induction of CD4 and susceptibility to HIV infection. J Exp Med 1995:181:13031310
27. Yamanishi K, Okuno T, Shiraki K, Takahashi M, Kondo T, Asano Y, et al. Identification of human herpesvirus-6 as a causal agent for exanthem subitum. Lancet 1988:1:1065-1067
28. Herbein G, Strasswimmer J, Altieri M, Woehl-Jaegle ML, Wolf P, Obert G. Longitudinal study of human herpesvirus 6 infection in organ transplant recipients. Clin Infect Dis 1996:22:171-173
29. Flamand L, Gosselin J, Stefanescu I, Ablashi D, Menezes J. Immunosuppressive effect of human herpesvirus 6 on T-cell functions: suppression of interleukin-2 synthesis and cell proliferation [published erratum appears in Blood 1995:86:418]. Blood 1995:85:12631271
30. Flamand L, Gosselin J, D'Addario M, Hiscott J, Ablashi DV, Gallo RC, et al. Human herpesvirus 6 induces interleukin-l and tumor necrosis factor alpha, but not interleukin-6, in peripheral blood mononuclear cell cultures. J Virol 1991:65:5105-5110
31. Inoue Y, Yasukawa M, Fujita S. Induction of T-cell apoptosis by human herpesvirus 6. J Virol 1997:71:3751-3759
32. Hall CB, Long CE, Schnabel KC, Caserta MT, Mclntyre KM, Costanzo MA, et al. Human herpesvirus-6 infection in children: a prospective study of complications and reactivation. N EnglJ Med 1994;331:432438
33. Brown NA, Sumaya CV, Liu CR, Ench Y, Kovacs A, Coronesi M, et al. Fall in human herpesvirus 6 seropositivity with age [letter]. Lancet 1988:2:396
34. Dockrell DH, Prada J, Jones MF, Patel R, Badley AD, Harmsen WS, et al. Seroconversion to human herpesvirus 6 following liver transplantation is a marker of cytomegalovirus disease. J Infect Dis 1997; 176:1135-1140
35. Okuno T, Higashi K, Shiraki K, Yamanishi K, Takahashi M, Kokado Y, et al. Human herpesvirus 6 infection in renal transplantation. Transplantation 1990:49:519-522
36. Merlino C, Giacchino F, Segoloni GP, Ponzi AN. Human herpesvirus-6 infection and renal transplantation [letter]. Transplantation 1992:53:1382-1383
37. Robert C, Agut H, Lunel-Fabiani F, Léger P. Infection a herpesvirus humain-6 et hépatite chez les transplantes cardiaques. Presse Med 1994:23:1209-1210
38. Ward KM, Gray JJ, EfstathiouS. Brief report: primary human herpesvirus 6 infection in a patient following liver transplantation from a seropositive donor. J Med Virol 1989:28:69-72
39. Jacobs U, Ferber J, Klehr HU. Severe allograft dysfunction after OKT3induced human herpes virus-6 reactivation. Transplant Proc 1994:26:3121
40. Pruksananonda P, Hall CB, Insel RA, Mclntyre K, Pellett PE, Long CE, et al. Primary human herpesvirus 6 infection in young children. N EnglJMed 1992:326:1445-1450
41. Hall CB. Human herpesviruses at sixes, sevens, and more [editorial]. Ann Intern Med 1997:127:481-483
42. Asano Y, Yoshikawa T, Suga S, Yazaki T, Kondo K, Yamanishi K. Fatal fulminant hepatitis in an infant with human herpesvirus-6 infection [letter]. Lancet 1990:335:862-863
43. Akashi K, Eizuru Y, Sumiyoshi Y, Minematsu T, Hara S, Harada M, et al. Brief report: severe infectious mononucleosis-like syndrome and primary human herpesvirus 6 infection in an adult. N Engl J Med 1993:329:168-171
44. Niederman JC, Liu CR, Kaplan MH, Brown NA. Clinical and serological features of human herpesvirus-6 infection in three adults. Lancet 1988:2:817-819
45. Eizuru Y, Minematsu T, Minamishima Y, Kikuchi M, Yamanishi K, Takahashi M, et al. Human herpesvirus 6 in lymph nodes [letter]. Lancet 1989;1:40
46. Challoner PB, Smith KT, Parker JD, MacLeod DL, Coulter SN, Rose TM, et al. Plaque-associated expression of human herpesvirus 6 in multiple sclerosis. Proc Natl Acad Sci USA 1995:92:7440-7444
47. Soldan SS, Berti R, Salem N, Secchiero P, Flamand L, Calabresi PA, et al. Association of human herpes virus 6 (HHV-6) with multiple sclerosis: increased IgM response to HHV-6 early antigen and detection of serum HHV-6 DMA. A/at Med 1997:3:1394-1397
48. Drobyski WR, Dunne WM, Burd EM, Knox KK, Ash RC, Horowitz MM, et al. Human herpesvirus-6 (HHV-6) infection in allogeneic bone marrow transplant recipients: evidence of a marrow-suppressive role for HHV-6 in vivo. J Infect Dis 1993;167:735-739
49. Singh N, Carrigan DR, Gayowski T, Marino IR. Human herpesvirus-6 infection in liver transplant recipients: documentation of pathogenicity. Transplantation 1997:64:674-678
50. Cone RW, Hackman RC, Huang M-LW, Bowden RA, Meyers JD, Metcalf M, et al. Human herpesvirus 6 in lung tissue from patients with pneumonitis after bone marrow transplantation. N Engl J Med 1993:329:156-161
51. Knox KK, Carrigan DR. Active human herpesvirus (HHV-6) infection of the central nervous system in patients with AIDS. J Acquir Immune Defic Syndr Hum Retrovirol 1995;9:69-73
52. Lusso P, Gallo RC. Human herpesvirus 6 in AIDS. Lancet 1994; 343:555-556
53. Lopez C, Pellett P, Stewart J, Goldsmith C, Sanderlin K, Black J, et al. Characteristics of human herpesvirus-6. J Infect Dis 1988:157:12711273
54. Saxinger C, Polesky H, Eby N, Grufferman S, Murphy R, Tegtmelr G, et al. Antibody reactivity with HBLV (HHV-6) in U.S. populations. J Virol Methods 1988:21:199-208
55. Secchiero P, Zella D, Crowley RW, Gallo RC, Lusso P. Quantitative PCR for human herpesviruses 6 and 7. J Clin Microbiol 1995:33:2124-2130
56. Secchiero P, Carrigan DR, Asano Y, Benedetti L, Crowley RW, Komaroff AL, et al. Detection of human herpesvirus 6 in plasma of children with primary infection and immunosuppressed patients by polymerase chain reaction. J Infect Dis 1995;171:273-280